Gene492
ATP2B3: ATPase plasma membrane Ca2+ transporting 3
13 sourcesgene-search-2026-11-13-0.2.1
Cite this record
ConductScience Library. ATP2B3: ATPase plasma membrane Ca2+ transporting 3. Genes, record 492. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/492
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q16720 | Plasma membrane calcium-transporting ATPase 3 | 1,220 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents122
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260337666 A1 | 2026-10-29 | 24982 | Q16720 | Espacenet |
| US 20260337666 A1 | 2026-10-29 | 24986 | Q16720 | Espacenet |
| US 20260193644 A1 | 2026-07-09 | 1791 | Q16720 | Espacenet |
| US 20260139247 A1 | 2026-05-21 | 510 | Q16720 | Espacenet |
| US 12577609 B2 | 2026-03-17 | 24982 | Q16720 | Espacenet |
| US 12577609 B2 | 2026-03-17 | 24986 | Q16720 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38185 | Q16720 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38186 | Q16720 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 1791 | Q16720 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 510 | Q16720 | Espacenet |
NIH grants260
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ATP2B3 papers | Newest fiscal year |
|---|---|---|---|
| U54GM115428 | Mississippi Center for Clinical and Translational Research | 16 | 2025 |
| R01DK043140 | Mechanisms Leading to Adrenal Zonation | 6 | 2025 |
| P30CA046592 | University of Michigan Rogel Cancer Center Support Grant 2023-2028 | 5 | 2025 |
| R01DK062027 | Mechanisms of Adrenal Differentiation | 4 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 3 | 2025 |
| P20GM121334 | Mississippi Center of Excellence in Perinatal Research, Phase 2 | 2 | 2025 |
| P30DK020572 | Michigan Diabetes Research Center (MDRC) | 2 | 2025 |
| R01DK115392 | Unrecognized Primary Aldosteronism as a Pathogenic Mechanism for Chronic Kidney Disease in Diabetes | 2 | 2025 |
| ZIADK043403 | Inhibition Of Renal Injury | 2 | 2025 |
| F30OD031914 | MicroRNA-375 regulation of enteroendocrine cell biology in diet-induced obesity and bariatric surgery | 1 | 2025 |
Source NIH's project files
Papers657
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of Ansamitocin P-3 Biosynthesis by the Response Regulator CrsB in Actinosynnema pretiosum. | Curr Microbiol | 2026 | 42809039 | PubTator, text mining | PubMed |
| Targeting Plasma Membrane Ca2+-ATPases in Cancer: Current Insights and Future Perspectives. | Cancers (Basel) | 2026 | 42588667 | PubTator, text mining | PubMed |
| Expanding the ATP2B3 Phenotype: Progressive Dystonia and Basal Ganglia Atrophy. | Pediatr Neurol | 2026 | 42468299 | PubTator, text mining | PubMed |
| Primary Hyperaldosteronism: Epidemiology, Diagnosis, and Clinical Associations. | Epidemiologia (Basel) | 2026 | 41873981 | PubTator, text mining | PubMed |
| Increased Frequency and Distinct Genotypic Patterns of Somatic Aldosterone-Driver Mutations in Aldosterone-Producing Micronodules from Primary Aldosteronism Patients. | Endocr Pathol | 2026 | 41857472 | PubTator, text mining | PubMed |
| ERRATUM: Intratumoural aldosterone and CYP11B2 expression levels among different genotypes of aldosterone producing tumours. | Endocr Connect | 2026 | 41759495 | PubTator, text mining | PubMed |
| Molecular pathology of primary aldosteronism and hypercortisolism: Impact on adrenal surgery. | iScience | 2026 | 41736857 | PubTator, text mining | PubMed |
| RNAseq-based meta-analyses revealed tumor suppressor-inducer fusion events in liver, oral, and ovarian cancer in the Indian population: a cancer cell surviving mechanism. | Nucleosides Nucleotides Nucleic Acids | 2026 | 41661231 | PubTator, text mining | PubMed |
| Somatic Drivers in Aldosterone-producing Adenomas and Nodules: Insights from a Brazilian Cohort of Primary Aldosteronism. | J Clin Endocrinol Metab | 2026 | 41498208 | PubTator, text mining | PubMed |
| Molecular investigation of primary aldosteronism: exploring genetic heterogeneity in understudied populations. | Arch Endocrinol Metab | 2025 | 41196931 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/492
GET https://conductscience.org/api/genes/v1/492/patents?page=2